Literature DB >> 35075215

Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation-dependence on GPR120.

Pei Liang1, Susanne M Henning1, Tristan Grogan2, David Elashoff2, Huihui Ye3, Pinchas Cohen4, William J Aronson5,6.   

Abstract

BACKGROUND: The antiprostate cancer effects of dietary ω-3 fatty acids (FAs) were previously found to be dependent on host G-protein coupled receptor 120 (GPR120). Using an orthotopic tumor model and an ex-vivo model of bone marrow derived M2-like macrophages, we sought to determine if ω-3 FAs inhibit angiogenesis and activate T-cells, and if these effects are dependent on GPR120.
METHODS: Gausia luciferase labeled MycCaP prostate cancer cells (MycCaP-Gluc) were injected into the anterior prostate lobe of FVB mice. After established tumors were confirmed by blood luminescence, mice were fed an ω-3 or ω-6 diet. Five weeks after tumor injection, tumor weight, immune cell infiltration and markers of angiogenesis were determined. An ex-vivo co-culture model of bone marrow derived M2-like macrophages from wild-type or GPR120 knockout mice with MycCap prostate cancer cells was used to determine if docosahexanoic acid (DHA, ω-3 FA) inhibition of angiogenesis and T-cell activation is dependent on macrophage GPR120.
RESULTS: Feeding an ω-3 diet significantly reduced orthotopic MycCaP-Gluc tumor growth relative to an ω-6 diet. Tumors from the ω-3 group had decreased M2-like macrophage infiltration and decreased expression of angiogenesis factors. DHA significantly inhibited M2 macrophage-induced endothelial tube formation and reversed M2 macrophage-induced T-cell suppression, and these DHA effects were mediated, in part, by M2 macrophage GPR120.
CONCLUSION: Omega-3 FAs delayed orthotopic tumor growth, inhibited M2-like macrophage tumor infiltration, and inhibited M2-like macrophage-induced angiogenesis and T-cell suppression. Given the central role of M2-like macrophages in prostate cancer progression, GPR120-dependent ω-3 FA inhibition of M2-like macrophages may play an important role in prostate cancer therapeutics.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35075215      PMCID: PMC9308823          DOI: 10.1038/s41391-021-00440-2

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.455


  51 in total

1.  Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.

Authors:  Theodore M Brasky; Cathee Till; Emily White; Marian L Neuhouser; Xiaoling Song; Phyllis Goodman; Ian M Thompson; Irena B King; Demetrius Albanes; Alan R Kristal
Journal:  Am J Epidemiol       Date:  2011-04-24       Impact factor: 4.897

2.  Pharmacodynamics of fish oil: protective effects against prostate cancer in TRAMP mice fed with a high fat western diet.

Authors:  Constance Lay Lay Saw; Tien-Yuan Wu; Ximena Paredes-Gonzalez; Tin Oo Khor; Douglas Pung; Ah-Ng Tony Kong
Journal:  Asian Pac J Cancer Prev       Date:  2011

3.  Bone Marrow-Derived Macrophages (BMM): Isolation and Applications.

Authors:  Joachim Weischenfeldt; Bo Porse
Journal:  CSH Protoc       Date:  2008-12-01

4.  Long chain omega-3 fatty acids and their oxidized metabolites are associated with reduced prostate tumor growth.

Authors:  Jean-François Bilodeau; Nikunj Gevariya; Jessica Larose; Karine Robitaille; Jérôme Roy; Camille Oger; Jean-Marie Galano; Alain Bergeron; Thierry Durand; Yves Fradet; Pierre Julien; Vincent Fradet
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2020-11-19       Impact factor: 4.006

5.  Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling.

Authors:  Lei-Ya Fang; Kouji Izumi; Kuo-Pao Lai; Liang Liang; Lei Li; Hiroshi Miyamoto; Wen-Jye Lin; Chawnshang Chang
Journal:  Cancer Res       Date:  2013-07-22       Impact factor: 12.701

6.  A prospective study of intake of fish and marine fatty acids and prostate cancer.

Authors:  Katarina Augustsson; Dominique S Michaud; Eric B Rimm; Michael F Leitzmann; Meir J Stampfer; Walter C Willett; Edward Giovannucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-01       Impact factor: 4.254

7.  Platelet factor 4 induces cell apoptosis by inhibition of STAT3 via up-regulation of SOCS3 expression in multiple myeloma.

Authors:  Pei Liang; Suk Hang Cheng; Chi Keung Cheng; Kin Mang Lau; Shek Ying Lin; Eudora Y D Chow; Natalie P H Chan; Rosalina K L Ip; Raymond S M Wong; Margaret H L Ng
Journal:  Haematologica       Date:  2012-08-28       Impact factor: 9.941

8.  Effect of a low-fat fish oil diet on proinflammatory eicosanoids and cell-cycle progression score in men undergoing radical prostatectomy.

Authors:  Colette Galet; Kiran Gollapudi; Sevan Stepanian; Joshua B Byrd; Susanne M Henning; Tristan Grogan; David Elashoff; David Heber; Jonathan Said; Pinchas Cohen; William J Aronson
Journal:  Cancer Prev Res (Phila)       Date:  2013-10-29

9.  Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis.

Authors:  Aerken Maolake; Kouji Izumi; Kazuyoshi Shigehara; Ariunbold Natsagdorj; Hiroaki Iwamoto; Suguru Kadomoto; Yuta Takezawa; Kazuaki Machioka; Kazutaka Narimoto; Mikio Namiki; Wen-Jye Lin; Guzailinuer Wufuer; Atsushi Mizokami
Journal:  Oncotarget       Date:  2017-02-07

Review 10.  Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention.

Authors:  Zhennan Gu; Janel Suburu; Haiqin Chen; Yong Q Chen
Journal:  Biomed Res Int       Date:  2013-05-23       Impact factor: 3.411

View more
  2 in total

Review 1.  The function of omega-3 polyunsaturated fatty acids in response to cadmium exposure.

Authors:  Zhi Chen; Qinyue Lu; Jiacheng Wang; Xiang Cao; Kun Wang; Yuhao Wang; Yanni Wu; Zhangping Yang
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

2.  Pancreatic Cancer Cell-Derived Exosomes Promote Lymphangiogenesis by Downregulating ABHD11-AS1 Expression.

Authors:  Xulin Zhou; Fengyun Zhong; Yongmin Yan; Sihui Wu; Huizhi Wang; Junqiang Liu; Feifan Li; Dawei Cui; Min Xu
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.